```json
{
"content": [
{
"type": "paragraph",
"content": "The Adult Artificial Heart Market encompasses implantable devices designed to replace or support failing hearts in advanced heart disease patients, addressing critical gaps in cardiac care. With the Adult Artificial Heart market size projected to exceed $650 million by 2033, the industry is poised for transformative growth driven by rising demand for durable solutions and regulatory advancements. This market forecast underscores strategic opportunities in industry expansion, particularly in regions with aging populations and underdeveloped transplant infrastructure."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Ventricular Assist Devices (VADs)", "Total Artificial Hearts (TAHs)", "Others"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[0.8, 0.9, 1.1, 1.3, 1.6, 1.9, 2.3, 2.7, 3.1, 3.6, 4.0, 4.5, 5.0], // VADs in $B
[0.3, 0.3, 0.4, 0.5, 0.6, 0.7, 0.9, 1.1, 1.4, 1.7, 2.0, 2.4, 2.8], // TAHs in $B
[0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1, 0.1] // Others in $B
]
}
},
{
"type": "paragraph",
"content": "The Adult Artificial Heart market is forecasted to grow at a compound annual growth rate (CAGR) of 7.2% from 2026–2033, fueled by breakthroughs in biocompatible materials, miniaturization of components, and FDA expedited approvals for next-gen devices. North America remains the largest market, dominated by U.S. adoption of VADs for bridge-to-transplant scenarios. Meanwhile, Asia-Pacific is the fastest-growing region, driven by rising cardiovascular disease prevalence and government-funded healthcare initiatives. Strategic partnerships between device manufacturers and telemedicine platforms will further catalyze market expansion, particularly in rural and underserved populations."
}
]
}
```
